---
title: "Formal FDA meetings that this playbook focuses on"
slug: "formal-fda-meetings-that-his-playbook-focuses-on"
updated: 2025-04-24T22:18:13Z
published: 2025-04-24T22:18:13Z
canonical: "bgtcplaybook.document360.io/formal-fda-meetings-that-his-playbook-focuses-on"
---

> ## Documentation Index
> Fetch the complete documentation index at: https://bgtcplaybook.document360.io/llms.txt
> Use this file to discover all available pages before exploring further.

# Formal FDA meetings that this playbook focuses on

For this playbook, we are focusing on the **INTERACT**, **Pre-IND**, and **IND** submissions and meeting types.

![Flowchart depicting the phases of a playbook. It starts with "Preclinical" and progresses through "Clinical Trials" (Phase 1, Phase 2, Phase 3), "Marketing Application," and ends with "Post-marketing." Each phase is represented by an arrow pointing to the next phase. Below these arrows are boxes indicating specific meetings or activities: "INTERACT Meeting," "Pre-IND Meeting," "End of Phase 1 Meeting," "End of Phase 2 Meeting," and two instances of "Pre-BLA Meeting."](https://cdn.document360.io/a7cea773-7486-41ac-bd50-afa0255ce01f/Images/Documentation/image-1738765415690.png)

Schematic representing focus of the playbook